This suggests that in addition to key enzyme molecules during glycolysis, Wnt2b/β-catenin/c-Myc signalling might also act as an important metabolic checkpoint in HCC-TAMs. The gene discussed is WNT2B; the disease is hepatocellular carcinoma.